KIDS - オ―ソピディアトリックス (OrthoPediatrics Corp.) オ―ソピディアトリックス

 KIDSのチャート


 KIDSの企業情報

symbol KIDS
会社名 OrthoPediatrics Corp (オ―ソピディアトリックス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 オルソペディアトリックス(OrthoPediatrics Corp.)は整形外科会社である。同社は小児外科医および患者の特殊ニーズを満たす整形外科用インプラントおよび器具を設計、開発、販売する。同社は整形外科問題を抱えた小児用インプラントやデバイスの設計、開発、販売を行うOrthoPediatrics事業を運営する。製品にはPediNail髄内ネイルシステム、PediLocめっきシステム、ACL再構築システム、LCBプレートシステム、Locking Proximal Femur(LPF)プレートシステム、PediFlex Flexible Nailing System、PediFrag、PediLoc拡張骨切り術用プレート(PLEO)、PediLoc 大腿固定プレートシステム、PediLoc脛骨固定プレートシステム、PediPlatesシステムおよびSpicaテーブルを含む。   オ―ソピディアトリックスは米国の医療器具メ―カ―。主に子供向けの整形外科用インプラントおよび器具の設計・開発・販売に従事する。同社は小児用大腿骨圧迫プレ―ト「PediLoc」や「PediPlates」、爪の「PediFlex」、脛骨、ACL再建システム、スクリュ―などの整形外科用の専門製品を提供する。本社所在地はインディアナ州ウォ―ソ―。   
本社所在地 2850 Frontier Drive Warsaw IN 46582 USA
代表者氏名 Terry D. Schlotterback テリー・D・シュロテルターバック
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 574-268-6379
設立年月日 39387
市場名 NASDAQ National Market System
ipoyear 2017年
従業員数 69人
url www.orthopediatrics.com
nasdaq_url https://www.nasdaq.com/symbol/kids
adr_tso
EBITDA EBITDA(百万ドル) -8.76200
終値(lastsale) 36.19
時価総額(marketcap) 462880558.91
時価総額 時価総額(百万ドル) 420.41680
売上高 売上高(百万ドル) 51.22700
企業価値(EV) 企業価値(EV)(百万ドル) 419.32380
当期純利益 当期純利益(百万ドル) -25.79200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Orthopediatrics Corp revenues increased 26% to $27.2M. Net loss applicable to common stockholders increased 42% to $7.7M. Revenues reflect U.S. segment increase of 22% to $20.1M International segment increase of 40% to $7.1M. Higher net loss reflects Sales and marketing increase of 35% to $12.9M (expense) General and administrative - Balancing increase of 46% to $8.9M (expense).

 KIDSのテクニカル分析


 KIDSのニュース

   BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages OrthoPediatrics Corp. Investors to Inquire About Class Action Investigation – KIDS - Stocks News Feed  2021/02/15 17:55:00 Stocks News Feed
NEW YORK, Feb. 15, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ:KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public. SO WHAT: If you purchased OrthoPediatrics securities… Read More »BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages OrthoPediatrics Corp. Investors to Inquire About Class Action Investigation – KIDS
   BREAKING NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages OrthoPediatrics Corp. Investors with Losses to Inquire About Class Action Investigation – KIDS - Stocks News Feed  2021/02/03 23:00:00 Stocks News Feed
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public. SO WHAT: If you purchased OrthoPediatrics… Read More »BREAKING NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages OrthoPediatrics Corp. Investors with Losses to Inquire About Class Action Investigation – KIDS
   OrthoPediatrics Announces Latest Screw System Launch in US  2020/03/12 08:33:00 Zacks Investment Research
OrthoPediatrics (KIDS) releases the latest cannulated screw system as part of its beta release to address trauma as well as other bone fixation procedures.
   OrthoPediatrics Corp. (KIDS) CEO Mark Throdahl on Q1 2019 Results - Earnings Call Transcript  2019/05/13 10:54:09 Seeking Alpha
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2019 Earnings Conference Call May 9, 2019 08:00 ET Company Participants Tram Bui - Investor Relations Mark Throdahl - Chi
   OrthoPediatrics in-licenses technology used in PediFoot  2019/04/22 20:44:55 Seeking Alpha
   OrthoPediatrics Announces Latest Screw System Launch in US  2020/03/12 08:33:00 Zacks Investment Research
OrthoPediatrics (KIDS) releases the latest cannulated screw system as part of its beta release to address trauma as well as other bone fixation procedures.
   OrthoPediatrics Corp. (KIDS) CEO Mark Throdahl on Q1 2019 Results - Earnings Call Transcript  2019/05/13 10:54:09 Seeking Alpha
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2019 Earnings Conference Call May 9, 2019 08:00 ET Company Participants Tram Bui - Investor Relations Mark Throdahl - Chi
   OrthoPediatrics in-licenses technology used in PediFoot  2019/04/22 20:44:55 Seeking Alpha
   The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering  2019/03/21 11:51:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) Cytokinetics, Inc. (NASDAQ: CYTK )(Following planned interim analysis, the company along with partner Amgen, Inc. (NASDAQ: AMGN ) (announced a large-scale Phase 3 study evaluating their cardiac myosin activator omecamtiv mecarbil in 8000 heart failure patients will continue unchanged.) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND ) Orthopediatrics Corp (NASDAQ: KIDS ) Qiagen NV (NYSE: QGEN ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 20) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evogene Ltd (NASDAQ: EVGN ) G1 Therapeutics Inc (NASDAQ: GTHX ) resTORbio, Inc. (NASDAQ: TORC ) (priced its common stock offering …
   The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company  2019/03/20 11:46:35 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 19) Abbott Laboratories (NYSE: ABT ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) CYCLERION THERA/SH (NASDAQ: CYCNV ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND )(initiates Phase 2b/3 study for its investigational candidate livoletide for treating Prader-Willi syndrome) Orthopediatrics Corp (NASDAQ: KIDS ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 19) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) resTORbio, Inc. (NASDAQ: TORC ) (announced a common stock offering) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stock In Focus Sage Gets FDA Approval For Postpartum Depression Drug SAGE Therapeutics Inc (NASDAQ: SAGE ) said the FDA has approved its Zulresso, chemically brexanolone, injection for the treatment of postpartum depression.
   OrthoPediatrics Announces Latest Screw System Launch in US  2020/03/12 08:33:00 Zacks Investment Research
OrthoPediatrics (KIDS) releases the latest cannulated screw system as part of its beta release to address trauma as well as other bone fixation procedures.
   OrthoPediatrics Corp. (KIDS) CEO Mark Throdahl on Q1 2019 Results - Earnings Call Transcript  2019/05/13 10:54:09 Seeking Alpha
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2019 Earnings Conference Call May 9, 2019 08:00 ET Company Participants Tram Bui - Investor Relations Mark Throdahl - Chi
   OrthoPediatrics in-licenses technology used in PediFoot  2019/04/22 20:44:55 Seeking Alpha
   The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering  2019/03/21 11:51:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) Cytokinetics, Inc. (NASDAQ: CYTK )(Following planned interim analysis, the company along with partner Amgen, Inc. (NASDAQ: AMGN ) (announced a large-scale Phase 3 study evaluating their cardiac myosin activator omecamtiv mecarbil in 8000 heart failure patients will continue unchanged.) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND ) Orthopediatrics Corp (NASDAQ: KIDS ) Qiagen NV (NYSE: QGEN ) Veracyte Inc (NASDAQ: VCYT ) XBiotech Inc (NASDAQ: XBIT ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 20) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Evogene Ltd (NASDAQ: EVGN ) G1 Therapeutics Inc (NASDAQ: GTHX ) resTORbio, Inc. (NASDAQ: TORC ) (priced its common stock offering …
   The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company  2019/03/20 11:46:35 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 19) Abbott Laboratories (NYSE: ABT ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) CYCLERION THERA/SH (NASDAQ: CYCNV ) Glaukos Corp (NYSE: GKOS ) Millendo Therapeutics Inc (NASDAQ: MLND )(initiates Phase 2b/3 study for its investigational candidate livoletide for treating Prader-Willi syndrome) Orthopediatrics Corp (NASDAQ: KIDS ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 19) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) resTORbio, Inc. (NASDAQ: TORC ) (announced a common stock offering) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stock In Focus Sage Gets FDA Approval For Postpartum Depression Drug SAGE Therapeutics Inc (NASDAQ: SAGE ) said the FDA has approved its Zulresso, chemically brexanolone, injection for the treatment of postpartum depression.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 オ―ソピディアトリックス KIDS OrthoPediatrics Corp.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)